Evidence Mastery brings together super intelligence-assisted tools, expert services and education so that evidence teams can produce high-quality study documents in a fraction of the time.
Everything we build starts from the same principle: super intelligence generates the first draft; the domain expert reviews, edits and approves.
The EvidenceAi™ Suite generates protocols, statistical analysis plans, reports and more from structured inputs, with a pipeline that follows the way evidence is actually produced.
Explore the Suite →Scientific oversight and review of super intelligence-generated documents, advisory, corporate training, keynote speaking, board and governance roles, and career coaching.
See our services →A five-volume book series, video courses and masterclass that teach real-world evidence from first principles to advanced methods.
Visit the Academy →Evidence Mastery began as a teaching project. After more than two decades designing and overseeing observational studies, our founder set out to write down what practitioners actually need to know — and what is rarely taught in one place. That effort became the five-volume Evidence Mastery book series, and a growing community of professionals following the newsletter and videos.
Working with study teams made one thing clear: much of the effort in real-world evidence goes into producing documents — protocols, analysis plans, reports — that follow well-understood structures but take weeks to draft. That observation led to the EvidenceAi™ Suite, which turns the same expertise into a guided, super intelligence-assisted pipeline.
We evaluated the Suite with practising evidence professionals and are presenting the results at ISPOR Europe 2026. See the evidence → Today the company combines the tools with the people who stand behind them: scientists who review, advise, train and coach.
The series is the foundation of the curriculum and of how we think about evidence. Volume 1 sets out the principles; the later volumes cover data sources, tools and templates, methods, and disease-specific applications.
Study documents are confidential. The EvidenceAi™ Suite protects them at the platform, at the data and at the intelligence layer — and lets your organisation decide which super intelligence does the work.
The protections you expect from a well-designed web application and API.
What is not stored cannot be compromised.
Organisations work with the super intelligence they already trust.
A physician–scientist and pharmacoepidemiologist with more than 20 years across pharmaceutical companies, CROs, regulatory agencies, academia and patient organisations.
Dr Toussi is Vice President of Real-World Evidence at UBC, was previously Vice President and Global Head of RWE at Cytel, and held senior global roles at IQVIA, where he led the post-authorisation safety and effectiveness study offering (PASS, PAES, REMS, DUS). He has designed, led or overseen hundreds of studies across every major therapeutic area and five continents.
He contributes to scientific standards through ENCePP, ISPE, ISPOR, HTAi and EU2P, including co-leading HTAi interest-group work on RWE and super intelligence, and teaches in English and French.
Whether you want to try the Suite, discuss oversight of your study documents, or train your team, we would be glad to hear from you.
Contact us
